• Contact IR
  • FAQS
  • Corporate Website
BioStem Technologies, Inc
Investor relations
  • Overview
  • News
  • Events & Presentations
    • Events
    • Latest Presentation
  • Financials
    • SEC Filings
    • Quarterly Results
    • Annual Reports
  • Stock Info
  • Resources
    • Board of Directors
    • Management Team
    • Scientific Advisory Board
    • Analysts
    • Investor Email Alerts
  • Corporate Website
Select Page

Latest News

Investor Relations

Latest News

Select Year:
November 6, 2023 08:30 am

BioStem Technologies to Report Third Quarter 2023 Financial Results on Tuesday, November 14, 2023

November 3, 2023 08:30 am

BioStem Technologies Closes Oversubscribed $2M Private Placement

October 24, 2023 08:30 am

BioStem Technologies Announces Opening of First Clinical Site for Diabetic Foot Ulcer Study

October 17, 2023 12:10 pm

BioStem Technologies to Highlight Core Advanced Wound Care Portfolio at SAWC Fall 2023 Conference

September 29, 2023 08:30 am

BioStem Technologies: CMS Decision a "Win For Patients"

September 26, 2023 08:30 am

BioStem Receives IRB Approval for Clinical Study to Evaluate Vendaje(R) in Diabetic Foot Ulcers

September 19, 2023 08:00 am

BioStem Technologies Initiates Nationwide Launch of AmnioWrap2(TM) with Venture Medical

September 18, 2023 08:30 am

BioStem Technologies Engages PCG Advisory for Strategic Investor Relations

September 6, 2023 12:00 pm

BioStem Awarded a Spot on ECAT, DAPA, and FSS Contract Vehicles Through SDVOSB, Lovell

March 23, 2023 07:30 am

BioStem Technologies Commends OIG's Recommendation for CMS to Address ASP Reporting Requirements for Skin Substitute Products

« Previous 1 … 4 5 6 7 8 9 Next »
  • Home
  • Our Science
  • Products
  • Resources
  • About Us
  • Contact Us
  • FAQS
  • CAREERS
  • TERMS AND CONDITIONS
  • PRIVACY POLICY
  • SHIPPING POLICY
  • REFUND POLICY
  • COOKIE POLICY
  • RSS
  • Instagram
  • X

© 2025 BioStem Technologies, Inc. All Rights Reserved. Use of this site is subject to certain Terms Of Use and Privacy Policy.

For screen reader problems with this website, please call (954) 380-8342 for assistance.

Disclaimer

You are about to review presentations, reports and/or filings of BioStem Technologies, Inc., that contain time-sensitive information. The information contained therein is only accurate as of the date thereof. BioStem Technologies, Inc. will not be reviewing or updating the material that is contained in these items after the date thereof. The information contained therein may be updated, amended, supplemented or otherwise altered by subsequent presentations, reports and/or filings by BioStem Technologies, Inc.

I Accept I Decline